Phase 4Recruiting
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
- Sponsor
- ARS Pharmaceuticals, Inc. (Industry)
- Enrollment
- 600 planned
- Conditions
- Allergic Reactions
- Interventions
- Neffy; Adrenaline
- Ages
- children, adults, older adults
- Registry
- NCT06834165
Full record on ClinicalTrials.gov
From the registry
The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.
Primary outcomes
- AEs after epinephrine treatment within 2 hours
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered